Dale Greiner to Rituximab
This is a "connection" page, showing publications Dale Greiner has written about Rituximab.
Connection Strength
0.091
-
Megathlin HR, Burzenski L, Brehm MA, Greiner DL, Balu-Iyer S, Shultz LD. Increased longevity of circulating human IgG in an NSG Fc gamma receptor-1 deficient humanized mouse model. J Pharm Sci. 2025 Oct; 114(10):103964.
Score: 0.058
-
Verma MK, Clemens J, Burzenski L, Sampson SB, Brehm MA, Greiner DL, Shultz LD. A novel hemolytic complement-sufficient NSG mouse model supports studies of complement-mediated antitumor activity in vivo. J Immunol Methods. 2017 07; 446:47-53.
Score: 0.033